Concerning proteoglycan expression in the neointima, both perlecan and versican have been shown to be present in neointimal lesions formed after experimental or human stenting or denudation or related to atherosclerosis [38]–[40]. This evidence concerns the gene HSPG2 and atherosclerosis.